Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study

被引:0
|
作者
Escobar, Carlos [1 ]
Palacios, Beatriz [2 ]
Villarreal, Miriam [2 ]
Gutierrez, Martin [2 ]
Capel, Margarita [3 ]
Aranda, Unai [4 ]
Hernandez, Ignacio [5 ]
Garcia, Maria [5 ]
Lledo, Laura [5 ]
Arenillas, Juan F. [6 ,7 ]
机构
[1] Univ Hosp La Paz, Dept Cardiol, Madrid 28046, Spain
[2] AstraZeneca, BioPharmaceut Med, Madrid 28050, Spain
[3] AstraZeneca, BioPharmaceut Corp Affairs & Market Access, Madrid 28050, Spain
[4] AstraZeneca, BioPharmaceut Med, Global Med Affairs, Gaithersburg, MD 20878 USA
[5] Atrys Hlth, Madrid 28002, Spain
[6] Hosp Clin Univ, Comprehens Stroke Ctr, Neurol Dept, Valladolid 47003, Spain
[7] Univ Valladolid, Dept Med, Clin Neurosci Res Grp, Valladolid 47003, Spain
关键词
atrial fibrillation; cost; direct oral anticoagulants; healthcare resource utilization; major bleeding; reversal agents; venous thromboembolism; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; WARFARIN; RIVAROXABAN; GUIDELINE; APIXABAN; EDOXABAN; SAFETY;
D O I
10.3390/jcm13144253
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Our aims were to describe the clinical characteristics, adverse clinical events, healthcare resource utilization (HCRU) and costs of patients with major bleeding during direct Factor Xa inhibitor (FXai) use. Methods: This is a retrospective cohort study that included secondary data from computerized health records of seven Spanish Autonomous Communities. Patients with a first major bleeding during treatment with a direct FXai were analyzed during a 3-year period. Results: Of 8972 patients taking a direct FXai, 470 (5.24%) had major bleeding (mean age (SD) 77.93 (9.71) years, 61.06% women). The most frequent indications for using FXais were atrial fibrillation (78.09%) and venous thromboembolism (17.66%). Among those with major bleeding, 88.94% presented with gastrointestinal bleeding, 6.81% intracranial bleeding, 2.13% trauma-related bleeding and 4.26% other major bleeding. Prothrombin complex concentrates were used in 63.19%, followed by transfusion of blood products (20.21%) and Factor VIIa (7.66%). In total, 4.26% of patients died in the hospital due to the first major bleeding. At the study end (after 3-year follow-up), 28.94% of the patients had died, 12.34% had a myocardial infarction and 9.15% an ischemic stroke. At year 3, overall bleeding cost was EUR 5,816,930.5, of which 79.74% accounted for in-hospital costs to treat the bleeding episode. Conclusions: Despite the use of replacement agents being high, major events were common, with a 29% mortality at the end of the follow up, and HCRU and costs were high, evidencing the need for new reversal treatment strategies.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] LONG-TERM COMPLICATIONS IN NON-SURGICALLY TREATED PATIENTS: A SINGLE-CENTER OBSERVATIONAL STUDY
    Tosco, Lorenzo
    Crivellaro, Simone
    Abbinnate, Maria
    Frea, Bruno
    ANTICANCER RESEARCH, 2011, 31 (05) : 1936 - 1937
  • [32] Long-term outcome of patients treated with cardiac resynchronisation. Results of a multicenter European observational study
    Auricchio, A.
    Metra, M.
    Gasparini, M.
    Lamp, B.
    Klersy, C.
    Fantoni, C.
    Curnis, A.
    Gronda, E.
    EUROPEAN HEART JOURNAL, 2005, 26 : 681 - 681
  • [33] Long-Term Clinical Outcomes of Chronic Hepatitis B Patients Treated with Entecavir Vs. Tenofovir: A Retrospective, Observational, Comparative Study
    Cho, Byeong Wook
    Jang, Ji Woong
    Chae, Hee Bok
    Kim, Suk Bae
    Song, Il Han
    HEPATOLOGY, 2018, 68 : 268A - 268A
  • [34] Regression of hepatic fibrosis in patients with chronic hepatitis C treated with direct-acting antivirals (DAAs). A long-term, prospective, observational study
    Avramopoulou, Evdoxia
    Tsounis, Efthymios
    Kanaloupitis, Stavros
    Zisimopoulos, Konstanitnos
    Kalafateli, Maria
    Aggeletopoulou, Ioanna
    Sotiropoulos, Christos
    Kafentzi, Theodora
    Geramoutsos, Georgios
    Ampazis, Odysseas
    Diamantopoulou, Georgia
    Tsintoni, Angeliki
    Thomopoulos, Konstantinos
    Triantos, Christos
    JOURNAL OF HEPATOLOGY, 2024, 80 : S830 - S830
  • [35] REGRESSION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS). A LONG-TERM OBSERVATIONAL STUDY.
    Triantos, Christos
    Kanaloupitis, Stavros
    Zisimopoulos, Konstantinos A.
    Aggeletopoulou, Ioanna
    Kalafateli, Maria
    Diamantopoulou, Georgia
    Tsintoni, Aggeliki
    Thomopoulos, Konstantinos
    GASTROENTEROLOGY, 2020, 158 (06) : S1323 - S1323
  • [36] Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
    Gonzalez-Corvillo, Carmen
    Beneyto, Isabel
    Sanchez-Fructuoso, Ana
    Perello, Manel
    Alonso, Angel
    Mazuecos, Auxiliadora
    Jimenez, Carlos
    Zarraga, Sofia
    Paul, Javier
    Lauzurica, Ricardo
    Hernandez, Domingo
    Guirado, Luis
    Franco, Antonio
    Carlos Ruiz, Juan
    Llorente, Santiago
    Crespo, Marta
    Rodriguez-Benot, Alberto
    de Gracia Guindo, Maria del Carmen
    Diaz-Corte, Carmen
    Angel Gentil, Miguel
    TRANSPLANTATION DIRECT, 2019, 5 (12):
  • [37] Long-Term Clinical Outcomes After Major versus Minor Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry
    Ishigami, Kenjiro
    Ogawa, Hisashi
    Ikeda, Syuhei
    Doi, Kosuke
    Hamatani, Yasuhiro
    Ide, Yuya
    Fujino, Akiko
    Ishii, Mitsuru
    Iguchi, Moritake
    Masunaga, Nobutoyo
    Esato, Masahiro
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Akao, Masaharu
    CIRCULATION, 2021, 144
  • [38] An observational long-term follow-up study of patients treated with high-dose oral calcitriol
    Alikhani, K.
    Kremenchutzky, M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S145 - S145
  • [39] An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
    Lim, Tae Seop
    Lee, Jae Seung
    Kim, Beom Kyung
    Lee, Hye Won
    Jeon, Mi Young
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (03) : 316 - 322
  • [40] Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study
    Shahrzad Salmasi
    Abdollah Safari
    Mary A. De Vera
    Tanja Högg
    Larry D. Lynd
    Mieke Koehoorn
    Arden R. Barry
    Jason G. Andrade
    Marc W. Deyell
    Kathy L. Rush
    Yinshan Zhao
    Peter Loewen
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 437 - 444